Clinical Trial Update: Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1 [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of sucralose on gut microbiota composition and postprandial GLP-1 levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• sucralose (sucralose)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: GLP-1, Gut Microbiota | NA | Status: COMPLETED